An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended-release tablets) in subjects with mild to moderate Alzheimer's disease
DescriptionA forum to discuss or ask questions about an open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended-release tablets) in subjects with mild to moderate Alzheimer's disease
